Cargando…
Oligodendrocyte progenitor cells proliferate and survive in an immature state following treatment with an axolemma-enriched fraction
The ability of an AEF (axolemma-enriched fraction) to influence the proliferation, survival and differentiation of OPC (oligodendrocyte progenitor cells) was evaluated. Following addition of AEF to cultured OPC, the AEF associated with the outer surface of OPC so that subsequent metabolic events wer...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Society for Neurochemistry
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3063503/ https://www.ncbi.nlm.nih.gov/pubmed/21345173 http://dx.doi.org/10.1042/AN20100035 |
_version_ | 1782200807088717824 |
---|---|
author | Becker-Catania, Sara G Nelson, Julie K Olivares, Shantel Chen, Shu-Jen DeVries, George H |
author_facet | Becker-Catania, Sara G Nelson, Julie K Olivares, Shantel Chen, Shu-Jen DeVries, George H |
author_sort | Becker-Catania, Sara G |
collection | PubMed |
description | The ability of an AEF (axolemma-enriched fraction) to influence the proliferation, survival and differentiation of OPC (oligodendrocyte progenitor cells) was evaluated. Following addition of AEF to cultured OPC, the AEF associated with the outer surface of OPC so that subsequent metabolic events were likely mediated by direct AEF-OPC contact. Addition of AEF to the cultured OPC resulted in a dose- and time-dependent increase in proliferation that was partially dependent on Akt (protein kinase B) and MAPK (mitogen-activated protein kinase) activation. The major mitogen in an AEF-SE (soluble 2.0 M NaCl extract of the AEF) was identified as aFGF (acidic fibroblast growth factor) and accounted for 50% of the mitogenicity. The remaining 50% of the mitogenicity had properties consistent with bFGF (basic fibroblast growth factor) but was not unequivocally identified. Under conditions that limit the survival of OPC in culture, AEF treatment prolonged the survival of the OPC. Antigenic and morphological examination of the AEF-treated OPC indicated that the AEF treatment helped the OPC survive in a more immature state. The potential downstream metabolic pathways potentially activated in OPC by AEF and the consequences of these activated pathways are discussed. The results of these studies are consistent with the view that direct contact of axons with OPC stimulates their proliferation and survival while preventing their differentiation. |
format | Text |
id | pubmed-3063503 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | American Society for Neurochemistry |
record_format | MEDLINE/PubMed |
spelling | pubmed-30635032011-03-28 Oligodendrocyte progenitor cells proliferate and survive in an immature state following treatment with an axolemma-enriched fraction Becker-Catania, Sara G Nelson, Julie K Olivares, Shantel Chen, Shu-Jen DeVries, George H ASN Neuro Research Article The ability of an AEF (axolemma-enriched fraction) to influence the proliferation, survival and differentiation of OPC (oligodendrocyte progenitor cells) was evaluated. Following addition of AEF to cultured OPC, the AEF associated with the outer surface of OPC so that subsequent metabolic events were likely mediated by direct AEF-OPC contact. Addition of AEF to the cultured OPC resulted in a dose- and time-dependent increase in proliferation that was partially dependent on Akt (protein kinase B) and MAPK (mitogen-activated protein kinase) activation. The major mitogen in an AEF-SE (soluble 2.0 M NaCl extract of the AEF) was identified as aFGF (acidic fibroblast growth factor) and accounted for 50% of the mitogenicity. The remaining 50% of the mitogenicity had properties consistent with bFGF (basic fibroblast growth factor) but was not unequivocally identified. Under conditions that limit the survival of OPC in culture, AEF treatment prolonged the survival of the OPC. Antigenic and morphological examination of the AEF-treated OPC indicated that the AEF treatment helped the OPC survive in a more immature state. The potential downstream metabolic pathways potentially activated in OPC by AEF and the consequences of these activated pathways are discussed. The results of these studies are consistent with the view that direct contact of axons with OPC stimulates their proliferation and survival while preventing their differentiation. American Society for Neurochemistry 2011-03-24 /pmc/articles/PMC3063503/ /pubmed/21345173 http://dx.doi.org/10.1042/AN20100035 Text en © 2011 The Author(s). http://creativecommons.org/licenses/by-nc/2.5/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Becker-Catania, Sara G Nelson, Julie K Olivares, Shantel Chen, Shu-Jen DeVries, George H Oligodendrocyte progenitor cells proliferate and survive in an immature state following treatment with an axolemma-enriched fraction |
title | Oligodendrocyte progenitor cells proliferate and survive in an immature state following treatment with an axolemma-enriched fraction |
title_full | Oligodendrocyte progenitor cells proliferate and survive in an immature state following treatment with an axolemma-enriched fraction |
title_fullStr | Oligodendrocyte progenitor cells proliferate and survive in an immature state following treatment with an axolemma-enriched fraction |
title_full_unstemmed | Oligodendrocyte progenitor cells proliferate and survive in an immature state following treatment with an axolemma-enriched fraction |
title_short | Oligodendrocyte progenitor cells proliferate and survive in an immature state following treatment with an axolemma-enriched fraction |
title_sort | oligodendrocyte progenitor cells proliferate and survive in an immature state following treatment with an axolemma-enriched fraction |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3063503/ https://www.ncbi.nlm.nih.gov/pubmed/21345173 http://dx.doi.org/10.1042/AN20100035 |
work_keys_str_mv | AT beckercataniasarag oligodendrocyteprogenitorcellsproliferateandsurviveinanimmaturestatefollowingtreatmentwithanaxolemmaenrichedfraction AT nelsonjuliek oligodendrocyteprogenitorcellsproliferateandsurviveinanimmaturestatefollowingtreatmentwithanaxolemmaenrichedfraction AT olivaresshantel oligodendrocyteprogenitorcellsproliferateandsurviveinanimmaturestatefollowingtreatmentwithanaxolemmaenrichedfraction AT chenshujen oligodendrocyteprogenitorcellsproliferateandsurviveinanimmaturestatefollowingtreatmentwithanaxolemmaenrichedfraction AT devriesgeorgeh oligodendrocyteprogenitorcellsproliferateandsurviveinanimmaturestatefollowingtreatmentwithanaxolemmaenrichedfraction |